Intracellular microRNAs (miRNAs) are key regulators of gene expression. The role of extracellular miRNAs in neuronal activation and sensory behaviors are unknown. Here we report an unconventional role of extracellular miRNAs for rapid excitation of nociceptor neurons via toll-like receptor-7 (TLR7) and its coupling to TRPA1 ion channel. miRNA-let-7b induces rapid inward currents and action potentials in dorsal root ganglion (DRG) neurons. These responses require the GUUGUGU motif, only occur in neurons coexpressing TLR7 and TRPA1, and are abolished in mice lacking Tlr7 or Trpa1. Furthermore, let-7b induces TLR7/TRPA1-dependent single-channel activities in DRG neurons and HEK293 cells overexpressing TLR7/TRPA1. Intraplantar injection of let-7b elicits rapid spontaneous pain via TLR7 and TRPA1. Finally, let-7b can be released from DRG neurons by neuronal activation, and let-7b inhibitor reduces formalin-induced TRPA1 currents and spontaneous pain. Thus, secreted extracellular miRNAs may serve as novel pain mediators via activating TLR7/TRPA1 in nociceptor neurons.
INTRODUCTION
MicroRNAs (miRNAs) are 18-25 nucleotide noncoding RNAs and bind the 3 0 UTRs of mRNAs to regulate gene expression posttranscriptionally (Bartel, 2004) . miRNAs have been implicated in various biological roles including neurodegeneration (Eacker et al., 2009) . Extracellular miRNAs are also present in circulating blood and cerebrospinal fluid in disease conditions (Lehmann et al., 2012) and binds toll-like receptor-7 (TLR7) (Fabbri et al., 2012) . TLR7 is activated by single-strand RNAs to initiate innate immune responses via transcriptional regulation (Takeuchi and Akira, 2010) . The miRNA lethal-7 (let-7), first discovered in the nematode as a key developmental regulator , is abundant and highly conserved across species . Interestingly, let-7 has been detected in the cerebrospinal fluid of patients with Alzheimer's disease (Lehmann et al., 2012) . Extracellular application of let-7b induces apoptosis of cortical neurons via activation of neuronal TLR7 and myeloid differentiation factor 88 (MyD88)-dependent transcriptional regulation of TNF-a (Lehmann et al., 2012) . miRNAs were also found in nociceptive primary sensory neurons (nociceptors) of dorsal root ganglion (DRG) to regulate pain and the expression of sodium channels (Zhao et al., 2010) . However, the unique role of secreted extracellular miRNAs in modulating the activation and excitability of sensory neurons and sensory behaviors is virtually unknown.
Recently, we have shown that TLR7 is expressed by smalldiameter DRG neurons (Liu et al., 2010) that are responsible for the sensations of pain and itch (Basbaum et al., 2009; Liu and Ji, 2013; Woolf and Ma, 2007) . Furthermore, the synthetic TLR7 ligands imiquimod and loxoribine induced rapid inward currents and action potentials in DRG nociceptor neurons (Liu et al., 2010) . However, the endogenous ligands of TLR7 remain to be identified. In this study, we evaluated whether extracellular miRNAs could serve as TLR7 agonists to rapidly activate DRG neurons and elicit pain and further determined functional coupling between TLR7 and ion channels.
RESULTS

Specific miRNAs Induce Inward Currents in DRG Neurons via TLR7 and TRPA1
We first tested whether let-7b, which contains immune stimulatory GUUGUGU motif ( Figure 1A ) for the activation of TLR7 (Heil et al., 2004) , would elicit electrophysiological responses in DRG neurons using patch-clamp recordings. Exposure of dissociated DRG neurons to let-7b, at the concentration of 7 mM (50 mg/ml), induced robust inward currents in small-diameter DRG neurons (<25 mm) of wild-type (WT) mice, and these currents were abolished in Tlr7 À/À mice, indicating a TLR7-dependent action ( Figures 1B and 1C) . However, the mutant oligoribonucleotide (Mut. oligo) with reduced GU content (Figure 1A ) (Lehmann et al., 2012) had no effects (Figures 1B) . We next asked whether TRPA1, expressed by TRPV1-positive nociceptors (Liu et al., 2010; Story et al., 2003) , is involved in miRNA-induced inward currents. We found all the let-7b-responsive neurons also responded to the TRPA1 agonist AITC (Jordt et al., 2004) (Figure 1B) . Notably, let-7b-induced inward currents were completely blocked by the TRPA1 antagonist HC030031 (100 mM) and eliminated in Trpa1 À/À mice ( Figures 1B and 1C ).
TLR7 agonist loxoribine (200 mM) also evoked inward currents ( Figure 1B ), which were abolished in Tlr7 À/À and Trpa1 À/À mice (data not shown).
I/V curve analysis further revealed that let-7b-evoked currents possess typical property of TRP channels: they are suppressed by HC030031 and have the reverse potential of 0 mV ( Figure 1D ). Dose-response curves of inward currents showed a left shift of the let-7b-elicited curve, compared to that elicited by AITC, loxoribine, and imiquimod, suggesting that let-7b has the highest efficacy for TRPA1 activation. The lowest concentration of let-7b that we tested to elicit inward current is 0.7 mM ( Figure 1E ). The amplitudes of inward currents induced by different miRNA and synthetic TLR7 ligands are summarized in Figure 1F .
We further assessed whether miRNA-induced neuronal activation is sequence dependent. miR-599, which also contains the GUUGUGU motif ( Figure 1A ), elicited TLR7-dependent induces action potentials only in TLR7-expressing neurons. Three neurons (3, 6, and 8, highlighted in red) respond to let-7b (7 mM) with action potentials and also express Tlr7, Trpa1, and Trpv1 mRNAs (indicated with *). M, molecular weights; n, negative control. Asterisks indicate TLR7-positive neurons.
current ( Figure S1A available online). By contrast, miR-29a and miR-21 (lacking the GUUGUGU motif; Figure 1A ) had no effects ( Figure 1F ; Figure S1B ). Of interest, let-7a ( Figure 1A ), a close family member of let-7b with a single nucleotide change in the GUUGUGU motif (GUUGUAU), failed to induce any inward current ( Figure 1F ; Figure S1C ). Together, these results suggest that GU-rich core (GUUGUGU) is critically required for inducing miRNA-induced inward currents. A database search (http://www.mirbase.org/) indicated that there are only a few miRNAs of Homo sapiens and Mus musculus that contain the motif (Table S1 ).
let-7b Induces Action Potentials in DRG Neurons that Coexpress TLR7 and TRPA1 let-7b (7 mM) evoked marked action potentials in DRG neurons, which were completely blocked by HC030031 and eliminated in Tlr7
-deficient neurons ( Figure 1G ; Figure S2A ). Loxoribine but not Mut. Oligo also induced action potentials in AITCresponsive neurons (Figure 1G; Figures S2A and S2B) . These data suggest that miRNA let-7b also causes excitation of sensory neurons via activation of TLR7 and TRPA1.
To further define whether TLR7 and TRPA1 are coexpressed in DRG neurons, we performed combined patch-clamp recording and single-cell PCR analysis (Liu et al., 2012a) in small-diameter DRG neurons. Around 30% of these neurons expressed TLR7, and all the TLR7-expressing neurons responded to let-7b and AITC with action potentials ( Figures 1H and 1I ) and inward currents ( Figures S3A-S3C ). These results suggest a perfect match between the expression and function of TLR7 in DRG neurons. Double staining also confirmed colocalization of TLR7 and TRPA1 in DRG neurons ( Figure S3D ). Of note, all the TLR7 + neurons contain TRPA1, which is expressed by the TRPV1 + DRG neurons (Figures 1H and 1I; Figure S3E ), as previously reported (Story et al., 2003) .
Intracellular Signaling Is Not Required for miRNAInduced Activation of DRG Neurons
MyD88 is an adaptor protein and critical for the conventional signaling of most TLRs including TLR7 and the transcription of inflammatory genes (Akira et al., 2006; Liu et al., 2012b) . In Myd88-deficient DRG neurons, let-7b-and AITC-induced inward currents were largely intact, although the amplitudes of currents were slightly reduced compared to that of WT neurons ( Figure 1F ; Figure S1D ). Thus, MyD88 is not essentially required for the let-7b-induced currents. Moreover, exposure of DRG neurons to inhibitors of PKA, PKC, PLC, ERK, and G proteins did not impair loxoribine-induced inward currents ( Figure S1E ), arguing against an involvement of intracellular signaling in the TLR7/TRPA1 interaction. Noxious compounds were shown to activate TRPA1 through covalent modification of cysteines (Macpherson et al., 2007) . However, the reducing agent dithiothreitol (DTT) did not affect the let-7b-induced inward current ( Figure S1F ), suggesting a possible noncovalent interaction between TLR7 and TRPA1. Although TLR3 detects double-strand RNAs (Akira et al., 2006) and double-strand total RNAs from brain tissues induced inward currents in DRG neurons via TLR3 (Liu et al., 2012a) , let-7b-induced inward currents are Tlr3 independent ( Figure 1F ).
let-7b Induces TRPA1-Mediated Inward Currents in HEK293 Cells
Can miRNA also activate TLR7 and TRPA1 in a heterologous cell system? To address this issue, we tested the actions of miRNA in HEK293 cells overexpressing TLR7/TRPA1. let-7b evoked robust inward currents in these cells, which were completely blocked by HC030031 (Figure 2A) . Notably, let-7b had no effect in HEK293 cells overexpressing TRPA1 alone ( Figure 2B ), confirming that TLR7 is essential for mediating the let-7b-induced currents in HEK293 cells. In contrast, TLR7 ligand failed to induce inward currents in HEK293 cells overexpressing TLR7/ TRPV1, TLR7/TRPV2, or TLR7/TRPV4 ( Figure 2C ). Thus, TLR7 selectively interacts with TRPA1 (but not with TRPV1, TRPV2, and TRPV4) to generate TRPA1-mediated inward currents in a heterologous cell system.
let-7b Binds TLR7 and Enhances TLR7/TRPA1 Interaction in HEK293 Cells Next, we investigated whether fluorescence-labeled let-7b (Cy3-let-7b) can bind TLR7 in HEK293 cells. Immunocytochemistry showed surface and cytoplasm expression of TLR7 in Tlr7-transfected cells but not in Tlr7 null cells ( Figure 2D ). Notably, we only observed Cy3-let-7b binding on TLR7-expressing cells (Figure 2D ). Triple staining of let-7b/TLR7/TRPA1 revealed colocalization of all three on the cell surface as well as in cytoplasm ( Figure 2D ), providing subcellular bases for TLR7/TRPA1 interaction. Coimmunoprecipitation with an anti-myc antibody in TLR7/ TRPA1-myc-expressing HEK293 cells revealed both TRPA1-myc and TLR7 bands ( Figures 2E and 2F ), suggesting a biochemical interaction of TLR7 and TRPA1. Of interest, a brief stimulation with let-7b (7 mM, 5 min) significantly increased the interaction of TLR7/TRPA1, as indicated by increased intensity of TLR7 band ( Figures 2E and 2F ).
let-7b Induces Single-Channel Activities of TRPA1 in DRG Neurons and HEK293 Cells
To further validate functional interaction of TLR7 and TRPA1 on the cell surface, we carried out single-channel recordings in both DRG neurons and HEK293 cells. Inside-out patch recordings in DRG neurons showed that intrapipette delivery of let-7b to the extracellular surface elicited voltage-dependent single-channel opening events, and the TRP channel property was validated by the I/V curve with the reversal potential = 0 mV ( Figures 3A  and 3B ). Inside-out patch recordings in HEK293 cells overexpressing TLR7/TRPA1 also demonstrated that let-7b could elicit HC030031-senstive single-channel activities ( Figure 3C ). Similarly, loxoribine induced single-channel activities of TRPA1 (data not shown). In contrast, HEK293 cells overexpressing TLR7/TRPV1 only demonstrated single-channel activities in response to capsaicin but not let-7b ( Figure 3D ). Together, these results suggest that let-7b could bind TLR7 on the extracellular surface to induce single-channel activities of TRPA1.
TLR7 Is Partially Required for the Function and Surface Expression of TRPA1 in DRG Neurons
To further assess the interaction of TLR7 and TRPA1 in DRG neurons, we evaluated TRPA1 currents in WT and Tlr7 À/À mice. Inside-out patch recordings in DRG neurons showed a significant Figures S4A and S4B ). Immunocytochemistry also revealed a significant reduction of surface expression of TRPA1 in Tlr7-deficient DRG neurons ( Figures  S4C and S4D ). As previously reported (Schmidt et al., 2009 ), AITC increased the surface expression of TRPA1 in WT mice. Both the basal and AITC-induced surface expression of TRPA1 were reduced in Tlr7 À/À mice ( Figures S4C and S4D ). These data indicate that TLR7 can modulate both the activity and surface expression of TRPA1.
Endogenous let-7b Release Contributes to FormalinInduced TRPA1 Currents in DRG Neurons Does endogenous miRNA also play a role in modulating neuronal activity? As previously reported (McNamara et al., 2007) , low concentration of formalin (0.01%) elicited TRPA1-mediated inward currents in DRG neurons ( Figures 4A, S1G , and S1H). Intriguingly, the formalin-induced inward current was significantly inhibited by a let-7b inhibitor (1 mM, anti-mmu-let-7b-5p) ( Figure 4A ). As expected, let-7b inhibitor blocked the let-7b-but not miR-599-induced currents ( Figure 4B ), validating a selective inhibition of let-7b.
let-7b Is Highly Expressed in DRGs and Released from DRG Neurons by Neuronal Activity
To determine the expression of let-7b in different tissues, we employed quantitative RT-PCR developed by QIAGEN (see Supplemental Experimental Procedures). Of interest, let-7b levels in DRG tissue are much higher than that of spinal cord, cortex, and skin tissues ( Figure 4C ). To further quantify miRNA release in DRG cultures, we introduced an exogenous miRNA, Caenorhabditis elegans miRNA-39 (cel-miRNA-39), as a spikein control. The basal release of let-7b in DRG cultures is around 10-25 pg/ml (z1.0 to 2.5 pM or 6 3 10 5 -1.5 3 10 6 copies/ml, MW = 7,133), depending on the density of the cultures ( Figure 4D ). This basal release is comparable to that of CGRP, a well-known pain mediator (Qin et al., 2008) . Apparently, let-7b release in DRG cultures is much higher than that in CSF (5,000 copy/ml) (Lehmann et al., 2012) . Formalin (0.01%) induced a densitydependent increase in let-7b release ( Figure 4D ). Activation of C-nociceptors with capsaicin and neuronal depolarization with KCl also increased let-7b release, suggesting an activity-dependent release ( Figure 4E ). However, AITC and the pruritogen chloroquine had no significant effects, because these agents only activate a very small population of DRG neurons ( Figure 4E ). Moreover, let-7b release was induced by ionomycine, an inducer of intracellular Ca 2+ increase ( Figure 4E ). The basal release of let-7a was also evident (z40 pg/ml) in DRG cultures. However, let-7a release was not increased by formalin, KCl, and capsaicin ( Figure 4E ). It is suggested that different mechanisms are involved in the release of let-7a and let-7b. We also found a quick basal release of let-7b in hindpaw skin preparation: within 5 min the let-7b concentration reached to 3.0 ± 0.5 pM (n = 6 mice).
Intraplantar Injection of let-7b Elicits Pain in Mice via TLR7 and TRPA1
Activation of small DRG neurons (nociceptors) is known to elicit pain (Basbaum et al., 2009; Caterina and Julius, 2001; Hucho and Levine, 2007; Woolf and Ma, 2007) . TRPA1 is an ancient molecule for chemosensation (Kang et al., 2010) and activation of TRPA1 triggers pain in rodents (Bautista et al., 2006; Patapoutian et al., 2009; Story et al., 2003) . We investigated whether extracellular (intraplantar) delivery of miRNAs would induce and 4G). Consistently, intraplantar pretreatment of HC030031 dose dependently suppressed let-7b-evoked spontaneous pain in wild-type mice ( Figure 4I) . Furthermore, at a low dose (1 mg, i.e., 9.3 mM in 15 ml), let-7b induced persistent (>3 hr) and TRPA1-dependent mechanical allodynia ( Figure 4J ). Strikingly, at the dose of 30 mg, let-7b induced long-lasting (>5 days) mechanical allodynia, which was reduced in Tlr7
and Trpa1 À/À mice ( Figures 4K and 4L ), as well as in Myd88
but not in Trpv1 À/À mice (data not shown). Intraplantar pretreatment of let-7b inhibitor reduced low-dose formalin (0.5%)-induced spontaneous pain in both phases ( Figure 4M ), suggesting an essential role of endogenous let-7b in inflammatory pain. Low-dose formalin (0.5%)-induced inflammatory pain was also reduced in Tlr7 À/À mice ( Figure 4N ). Thus, extracellular let-7b is both sufficient and required for inducing inflammatory pain via the activation of TLR7 and TRPA1.
DISCUSSION
We have identified an action of extracellular miRNAs (e.g., let-7b) for direct activation and excitation of nociceptor neurons. let-7b induced rapid (within a minute) inward currents and actions potentials, and these effects require TLR7 but not TLR3. We also demonstrated that let-7b binds TLR7 on the surface of TLR7-expressing HEK293 cells. Notably, let-7b is more potent than the synthetic TLR7 agonists loxoribine and imiquimod in inducing inward currents in DRG neurons and is also sufficient to induce TLR7-dependent inward currents in heterologous HEK293 cells. We found that miRNAinduced neuronal activation is sequence dependent and requires the GUUGUGU motif. Thus, miR-599 but not miR-29a and miR-21 evoked TLR7-dependent inward currents. Strikingly, let-7a, a close family member of let-7b, failed to induce any inward current, although both were shown to induce TLR7 and MyD88-dependent TNF-a release in immune cells (Lehmann et al., 2012) . Thus, the extracellular actions of miRNAs are highly selective.
Another important finding of this study is that we identified a functional interaction of TLR7 and TRPA1 in both DRG neurons and HEK293 cells. First, TLR7 is completely colocalized with TRPA1 in small TRPV1-expressing DRG neurons. Second, let-7b-induced inward currents (with reverse potential of 0 mV) and action potentials were abolished in Trpa1-deficient DRG neurons and blocked by the TRPA1 antagonist HC030031. In contrast, let-7b failed to evoke inward currents in HEK293 cells overexpressing TLR7/TRPV1, TLR7/TRPV2, and TLR7/TRPV4, supporting a selective interaction of TLR7 with TRPA1. Third, TLR7 and TRPA1 can be coimmunoprecipitated in HEK293 cells, and this biochemical interaction of TLR7/TRPA1 was enhanced in response to let-7b stimulation. Fourth, inside-out recordings in DRG neurons and HEK293 cells demonstrated that let-7b was sufficient to induce single-channel activities of TRPA1 in these cells, supporting a functional interaction of TLR7/TRPA1 on the extracellular surface. Fifth, intracellular signaling (e.g., MyD88, PKA, PKC, PLC, and MAPK signaling) is dispensable for this interaction. Finally, TRPA1 single-channel activities and surface expression were reduced in Tlr7-deficinet DRG neurons. Although all these lines of evidence support a functional interaction of TLR7 and TRPA1, further studies are needed to investigate protein-protein interaction between TLR7 and TRPA1.
Activation of TRPA1 in peripheral terminals of nociceptive neurons is known to evoke pain (Bautista et al., 2006; Patapoutian et al., 2009; Story et al., 2003) . Intraplantar injection of let-7b also elicited rapid nocifensive pain via TLR7 and TRPA1 but not TRPV1. Moreover, let-7b induced persistent mechanical allodynia through TLR7 and TRPA1. Of interest, let-7b is highly enriched in DRG tissues and endogenous let-7b can be released from DRG neurons in an activity-dependent manner. Although our findings point to an unconventional signaling of TLR7 via TRPA1, we should not rule out the role of MyD88, especially in the maintenance phase of persistent pain. We should also point out the discrepancy between the let-7b concentrations for eliciting physiological effects (mM) and the let-7b concentrations detected in DRG culture medium (pM). Such discrepancy was also found for CGRP (pM versus mM) (Qin et al., 2008) , a wellknown pain mediator. Given the facts that (1) RNAs are generally unstable and (2) in vivo local concentrations of let-7b near axons should be much higher than that in culture medium, let-7b may reach physiological concentrations (mM) after tissue injury to activate TLR7 and TRPA1. Importantly, let-7b inhibitor significantly reduced formalin-induced inflammatory pain.
In summary, we have demonstrated an unconventional extracellular role of specific miRNAs with the GUUGUGU motif (e.g., let-7b) for direct activation and excitation of nociceptive sensory neurons to evoke pain via TLR7 and TRPA1. Thus, secreted miRNAs may represent a new class of pain mediators. Secreted let-7b was implicated as a biomarker for disease (Lehmann et al., 2012) . Also, let-7b changes in DRGs and circulation were found in chronic pain conditions (Orlova et al., 2011; von Schack et al., 2011; Zhao et al., 2010) . Future studies are necessary to determine the tissue origins of miRNAs (e.g., let-7b) detected in circulation.
EXPERIMENTAL PROCEDURES
See a detailed description in the Supplemental Experimental Procedures.
Reagents
We purchased miRNAs from Integrated DNA Technologies, fluorescenceconjugated siRNA (Cy3-let-7b) from Sigma, and let-7b inhibitor from QIAGEN.
Animals
Knockout mice lacking Tlr7, Tlr3, Trpa1, Trpv1, and Myd88 and corresponding WT control mice (B6129PF2/J background for Trpa1; C57BL/6 background for Tlr7, Tlr3, Trpv1, and Myd88) were obtained from Jackson Laboratories. All the knockout mice were viable and showed no developmental defects. Young mice (4-5 weeks) were used for electrophysiological studies in DRG neurons. Adult male mice (8-10 weeks) of knockout mice and corresponding wild-type control mice, as well as CD1 mice, were used for behavioral and pharmacological studies. All the animal procedures were approved by the Institutional Animal Care & Use Committee of Duke University.
Whole-Cell and Inside-Out Single-Channel Recordings Whole-cell patch-clamp recordings in DRG neurons (small sizes, <25 mm) and HEK293 cells were performed at room temperature using an Axopatch-200B amplifier. To record inward currents, we conducted voltage clamp at holding membrane potential of À70 mV. Inside-out patch-clamp recordings were also performed at room temperature.
Pain Behavior Test
Intraplantar injection (10 ml) was made by a 27G needle. miRNA-evoked spontaneous pain was assessed by measuring the time (seconds) mice spent on licking, lifting, or flinching the affected paw in 5 min. All the behaviors were tested blindly.
Statistical analyses
All data were expressed as mean ± SEM and analyzed using Student's t test (two groups) or one-way ANOVA followed by post hoc Bonferroni test. The criterion for statistical significance was p < 0.05. (A) Inhibition of formalin (0.01%)-induced inward currents by let-7b inhibitor (anti-mmu-let-7b-5p, 1 mM). Right: amplitude of formalin-induced currents after being normalized to control. *p < 0.05, n = 12-15 neurons. (B) Blockade of let-7b-but not miR-599-induced currents in AITC-sensitive DRG neurons by let-7b inhibitor. n = 7-8 neurons. (C) let-7b expression levels in DRG, spinal cord, cortex, and skin tissues, assessed by quantitative RT-PCR and normalized to miRNA SNORD96A (a housekeeping miRNA). *p < 0.05, compared to spinal cord, cortex, and skin, n = 3 mice. (D) let-7b release in DRG cultures at different neuronal densities before and after formalin treatment (0.01%, 30 min). let-7b levels in culture medium were assessed by quantitative RT-PCR and normalized to spike-in cel-miRNA-39. *p < 0.05, two-way ANOVA, n = 3 cultures. (E) let-7b and let-7a release (fold of control) in DRG culture medium following 30 min treatment of formalin (0.01%), ionomycin (10 ng/ml), KCl (50 mM), capsaicin (1 mM), AITC (300 mM), or chloroquine (1 mM). *p < 0.05, compared to control, n = 4-12 cultures. 
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